A six-month trial at Penn State University proved that Setria Glutathione supplements raised blood and cell glutathione after one, three and six months
Resilience has used the money to add manufacturing capacity
The study found no increase in pancreatic cancer risk with GLP-1RA use, and several sensitivity analyses suggested a modest, non-significant reduction in incidence (Wang et al., 2025)
What employers need to know about the new oral GLP-1 Wegovy The treatment of obesity and cardiometabolic-related conditions has been transformed by GLP-1 medications, and new developments in this rapidly evolving market tend to make headlines
Shor, R
Wang YP, Lin HP, Chen HM, Kuo YS, Lang MJ, Sun A